From RNA interference breakthroughs in 2006 to the discovery of mRNA nucleotide modification in 2023, and now the Nobel Prize-winning miRNA research, RNA technology is rewriting the rules of medicine.
 
The COVID-19 pandemic propelled mRNA vaccines into the global spotlight, demonstrating the transformative potential of RNA-based therapies. But this success was decades in the making. Now, with the world riding the nucleic acid therapy wave, RNA is set to dominate the next decade of drug development.
 
How can Taiwan seize this moment to lead in RNA innovation?
The synergy between local biotech R&D and CDMO partnerships is key to unlocking global opportunities. But challenges in scaling, regulation, and funding must be addressed.
 
Stay ahead of the nucleic acid revolution with insights from industry leaders and experts.
 
Read more in Globalbio Vol.122: https://news.gbimonthly.com/tw/magazine/show.php?num=131
#RNARevolution #mRNAInnovation #GlobalBiotech #TaiwanBiotech #CDMO